PMC:7377212 / 238-434 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T6","span":{"begin":4,"end":15},"obj":"NCBITaxon:1"},{"id":"T7","span":{"begin":72,"end":80},"obj":"SP_7"},{"id":"T8","span":{"begin":107,"end":118},"obj":"UBERON:0001004"},{"id":"T9","span":{"begin":157,"end":162},"obj":"NCBITaxon:10239"}],"text":"thy individuals, as well as those with common comorbidities [1]. Severe COVID-19 is characterised by acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis, treatment of which m"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T7","span":{"begin":72,"end":80},"obj":"Disease"},{"id":"T8","span":{"begin":101,"end":136},"obj":"Disease"},{"id":"T9","span":{"begin":107,"end":136},"obj":"Disease"},{"id":"T10","span":{"begin":138,"end":142},"obj":"Disease"},{"id":"T11","span":{"begin":163,"end":174},"obj":"Disease"}],"attributes":[{"id":"A7","pred":"mondo_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0009971"},{"id":"A10","pred":"mondo_id","subj":"T10","obj":"http://purl.obolibrary.org/obo/MONDO_0006502"},{"id":"A11","pred":"mondo_id","subj":"T11","obj":"http://purl.obolibrary.org/obo/MONDO_0043905"}],"text":"thy individuals, as well as those with common comorbidities [1]. Severe COVID-19 is characterised by acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis, treatment of which m"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":107,"end":127},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0002098"}],"text":"thy individuals, as well as those with common comorbidities [1]. Severe COVID-19 is characterised by acute respiratory distress syndrome (ARDS) secondary to viral pneumonitis, treatment of which m"}